Mobile-health Network Solutions Class A Ordinary Shares logo

Mobile-health Network Solutions Class A Ordinary Shares(MNDR)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$0.94
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for MNDR

11/13/2026: MNDR (1-star) is currently NOT-A-BUY. Pass it for now.

Mobile-health Network Solutions (MNDR) is a growing player in the digital telehealth sector, providing a platform for remote patient-provider consultations. Its primary strength lies in its specialized mobile-first approach, which aims to simplify access to healthcare. The company's growth story centers on scaling its user base and enhancing its provider network, though it faces substantial execution risks. Major challenges include intense competition from well-capitalized telehealth incumbents and potential regulatory shifts. The stock may suit growth-oriented investors with a high risk tolerance who are looking for exposure to the evolving digital health landscape, provided they closely monitor user retention and market expansion progress.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitThe company is in an early growth phase, offering potential upside if it can capture market share, though it carries significant execution risks.
Momentum investorMixed fitMomentum is highly conditional on sustained positive price action and adoption signals that are currently evolving.
Value investorWeak fitThe company is an early-stage growth play, making traditional value metrics like P/E ratio less relevant or unfavorable.
Dividend investorWeak fitThe company does not pay a dividend and is focused on reinvesting capital for growth.
Low-risk investorWeak fitThe inherent volatility and execution risks of an early-stage healthcare tech company are generally unsuitable for risk-averse investors.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighAs a smaller, growth-oriented stock, MNDR is subject to significant price swings based on market sentiment.
Valuation riskMedium / highThe stock's valuation is highly dependent on future growth expectations which may be impacted by market conditions.
Competition risk (Digital health incumbents)HighCompeting against established giants with significant marketing and R&D budgets poses a constant threat to market share.
Business qualityMediumThe platform is early-stage, and long-term moat durability remains to be proven.
Dividend incomeLow / noneInvestors should not expect income, as the company retains all cash for growth.
Execution riskHighThe company's success depends on effectively managing its provider network and scaling its platform amidst regulatory scrutiny.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.31M USD
Price to earnings Ratio -
1Y Target Price 8
Price to earnings Ratio -
1Y Target Price 8
Volume (30-day avg) 7.3M shares
Beta -0.73
52 Weeks Range 0.71 - 32.52
Updated Date 11/14/2026
52 Weeks Range 0.71 - 32.52
Updated Date 11/14/2026
Dividends yield (FY) -
Basic EPS (TTM) -30.64

Sector & Industry Intelligence

Sector

Healthcare

Bullish
Sentiment
Strong Bullish
Momentum
Momentum Steady
BUY participation
62.6%
Active BUY / eligible
72 / 115
30-Day BUY Count Change
+35
Market state
Strong Bullish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Health Information Services

BUY participation
100.0%
Active BUY / eligible
4 / 4
30-Day BUY Count Change
+2

Eligible universe: 4 stocks.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type Stock
Historic Profit -19.78%
Avg. Invested days 7
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
MNDR receives a 2-star rating, reflecting soft or weak scores across the available pillars. The rating is constrained by weak unit economics, and weak price momentum.

Company Fundamentals

★★★★★
MNDR has moderate overall fundamentals (3 stars), with soft financial health, moderate growth momentum, and solid ownership. In FY2026 versus FY2025, moderate earnings growth (+5.8%) is partially offset by weak cash generation (FCF margin -19.8%), moderate revenue growth (+1.2%), weak profitability (net margin -41.2%).

Financial Health Rating

★★★★★
MNDR's financial health is soft, with the relatively strongest area being solid liquidity, including working-capital and asset support (WC/assets 36.9%). Profitability is weak (1 stars), which helps explain the 2-star overall score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is MNDR's strongest growth driver at +65.4% FY2026 versus FY2025 (strong, 5 stars). By comparison, while revenue growth (+1.2%, moderate) and earnings growth (+5.8%, moderate) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 0.7% and approximately 90.6% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 11.52% supports management-shareholder alignment.

Top 5 Institutional Investors

HRT FINANCIAL LLC 1.40%
Citadel Advisors Llc 0.89%
UBS Group AG 0.66%
SBI Securities Co Ltd 0.00%
Virtu Financial LLC 0.00%

Unit Economics (Per $1K Revenue)

★★★★★
MNDR generates approximately $-153 of gross profit, $-414 of operating income, and $-198 of free cash flow for every $1,000 of revenue. Based on FY2026 results. Operating losses and cash burn explain the 1-star rating, with weak cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 0.00%

Quantitative Style Profile

★★★★★
MNDR has a liquid, relatively low-volatility profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedLow VolatilitySmall / Mid Cap RiskShort Squeeze RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Telehealth ServicesSubscription and per-consultation fees generated from the use of its virtual healthcare platform.The company makes money by charging fees for the digital connections it facilitates between patients and doctors.

Valuation

Trailing PE -
Forward PE -
Enterprise Value -1.10M
Price to Sales(TTM) 0.17
Enterprise Value -1.10M
Price to Sales(TTM) 0.17
Enterprise Value to Revenue 0.04
Enterprise Value to EBITDA -291.96
Shares Outstanding 1.08M
Shares Floating 978.12K
Shares Outstanding 1.08M
Shares Floating 978.12K
Percent Insiders 11.52
Percent Institutions 0.69

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.